The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection

Cancer

Volumn 82, Issue 6, 1998, Pages 1013-1018

  Azuma, Takeshi ^a   Ito, Shigeji ^a   Sato, Fukiko ^a   Yamazaki, Yukinao ^a   Miyaji, Hideki ^a   Ito, Yoshiyuki ^a   Suto, Hiroyuki ^a   Kuriyama, Masaru ^a   Kato, Takuji ^b   Kohli, Yoshihiro ^c  

^a UNIVERSITY OF FUKUI   (Japan)

^b FUKUI PREFECTURAL UNIVERSITY   (Japan)

^c Aiseikai Yamashina Hospital   (Japan)

Author keywords

Atrophic gastritis; Gastric adenocarcinoma; Helicobacter pylori (H. pylori) infection; HLA DQA1

Indexed keywords

HLA DQ ANTIGEN; PEPSINOGEN; PEPSINOGEN II;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CONTROLLED STUDY; DISEASE RESISTANCE; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ALLELES; DISEASE SUSCEPTIBILITY; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HLA-DQ ANTIGENS; HUMANS; IMMUNITY, NATURAL; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0032521053     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980315)82:6<1013::AID-CNCR2>3.0.CO;2-F     Document Type: Article

References (33)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-31.
2. Nomura A, Stemmermann GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
3. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
4. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75:2789-93.
5. Lee A. Helicobacter pylori-initiated ulcerogenesis: look to the host. Lancet 1993;341:280-1.
6. Topalian SL, Rivoltini L, Mancini M, Markus NR, Robbins PF, Kawakami Y, et al. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 1994; 91:9461-5.
7. Takahashi T, Chapman PB, Yang SY, Hara I, Vijayasaradhi S, Houghton AN, et al. CD4+ T lymphocytes against human melanoma. J Immunol 1995;154:772-9.
8. Peace DJ, Chen W, Nelson H, Cheever MA. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J Immunol 1991;146:2059-65.
9. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994;343:542-3.
10. Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986;90:570-6.
11. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991;44:326-8.
12. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
13. Ota M, Seki T, Nomura N, Sugimura K, Mizuki N, Fukushima H, et al. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991;38:60-71.
14. Kimura Y, Ata M, Miyagawa N, Fujii T, Tanada S, Iio A, et al Fundamental evaluation of an IRMA assay kit for pepsinogen I and II. Kaku Igaku 1989;26:1217-21.
15. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences - a study of twins. Ann Intern Med 1994;120:982-6.
16. Campbell RD, Trowsdale T. Map of the human MHC. Immunol Today 1993;14:349-52.
17. Pullen AM, Marrack P, Kappler J. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 1988;335:796-801.
18. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33-9.
19. Silver ML, Guo HC, Strominger JL, Wiley DC. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992;360:367-9.
20. + T-cell immunity to mutated ras protein in pancreatic and colon cancer patients. Cancer Res 1995; 55:2984-7.
21. Wank R, Thompssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991;352:723-5.
22. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. West African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
23. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contributes to susceptibility and resistance to insulin-diabetes mellitus. Nature 1987;329:599-604.
24. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148:249-58.
25. van Endert PM, Lopez MT, Patel SD, Monaco JJ, McDevitt HO. Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. Proc Natl Acad Sci USA 1992;89:11594-7.
26. Carrington M, Colonna M, Spies T, Stephens JC, Mann DL. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993;37:266-73.
27. Ito S, Kohli Y, Kato T, Murakita H, Ohtaki Y, Hirai M, et al. Differences in urease activity in live Helicobacter pylori cultured from patients with gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7(Suppl 1):S83-5.
28. Murakita H, Hirai M, Ito S, Azuma T, Kato T, Kohli Y. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients. Eur J Gastroenterol Hepatol 1994;6(Suppl 1):S29-31.
29. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
30. Murakita H, Hirai M, Ito S, Azuma T, Kato T, Kohli Y, et al. Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophic gastritis or duodenal ulcer. J Gastroenterol Hepatol 1996;11:819-24.
31. Ito S, Azuma T, Murakita H, Hirai M, Miyaji H, Ito Y, et al. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996;39:800-6.
32. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994;56:56-60.
33. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.